0001922830-26-000003.txt : 20260421 0001922830-26-000003.hdr.sgml : 20260421 20260421133349 ACCESSION NUMBER: 0001922830-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260421 DATE AS OF CHANGE: 20260421 EFFECTIVENESS DATE: 20260421 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Pearl Diagnostics, Inc. CENTRAL INDEX KEY: 0001922830 ORGANIZATION NAME: EIN: 880762972 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-581278 FILM NUMBER: 26878183 BUSINESS ADDRESS: STREET 1: 1812 ASHLAND AVENUE STREET 2: SUITE 100 CITY: BALTIMORE STATE: MD ZIP: 21205 BUSINESS PHONE: 443.742.0250 MAIL ADDRESS: STREET 1: 1812 ASHLAND AVENUE STREET 2: SUITE 100 CITY: BALTIMORE STATE: MD ZIP: 21205 D 1 primary_doc.xml X0708 D LIVE 0001922830 Pearl Diagnostics, Inc. 1812 ASHLAND AVENUE SUITE G32 BALTIMORE MD MARYLAND 21205 410.614.0300 DELAWARE MycoMed Technologies, LLC MycoMedDx Inc. None Corporation true 2022 Kieren Marr 1812 Ashland Avenue Suite G32 Baltimore MD MARYLAND 20205 Executive Officer Director Brad Spellberg 1812 Ashland Avenue Suite G32 Baltimore MD MARYLAND 20205 Director John Cammack 1812 Ashland Avenue Suite G32 Baltimore MD MARYLAND 20205 Director Eric Gornstein 1812 Ashland Avenue Suite G32 Baltimore MD MARYLAND 21205 Executive Officer Director Biotechnology Decline to Disclose 06b false 2026-03-19 false true false 56544 11150000 11150000 0 false 21 0 0 500000 true false Pearl Diagnostics, Inc. /s/ Eric Gornstein Eric Gornstein Chief Executive Officer 2026-04-02